ArticlePublic health challenges2022
The blame game of the US baby formula crisis.
Article in Public health challenges, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Race, Breastfeeding Support, and the U.S. Infant Formula Shortage: An Exploratory Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Tilting the Scale: Current Provider Perspectives and Practices on Breastfeeding with HIV in the United States.AIDS patient care and STDs · 2023Article
- The blame game of the US baby formula crisis.Public health challenges · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The United States cannot meet the demand for infant formula. The nation is currently experiencing a problem due to the industry being controlled by a small number of enterprises, states relying on a single supplier, and a ban on importing infant formula from other nations. The four major corporations' control 89% of the domestic infant formula market creating an industry monopoly within the United States. Second, the dependence of separate states on a single baby formula provider is the cause of the infant formula shortage. In exchange for granting monopolies to formula producers inside specific areas, the federal government is given price cuts on baby formula goods, enabling it to pay for the acquisition. Finally, the United States's inability to import infant formula has significantly exacerbated the current scarcity. However, in the meanwhile, President Joe Biden's administration has put stopgap measures in place to end this shortage, like loosening limits on imports from abroad, but these measures are unlikely to provide long-term remedies. A multi-level strategy with long-lasting structural adjustments is required to avert future infant formula shortages in the United States, but for the time being, caregivers must find individual-level solutions to meet their children's nutritional needs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.